With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Listen here.
With $1.3bn invested in over 200 high-tech start-ups, OurCrowd is now sharpening its focus on medtech. Medtech Insight spoke to founder Jon Medved to find out more.
Listen here.
![[OurCrowd’s Denes Ban in The Business Times] Major VC player from Israel plans Asia fund, but says it’ll watch out for froth](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
